Korean J Urol.  1965 Jun;6(1):39-43.

Clinical experience with protermycin in genitourinary diseases

Affiliations
  • 1Department of Urology, St. Mary's Hospital, Catholic Medical College, Seoul, Korea.

Abstract

Protermycin, the first molecular synthetic of tetracycline and chloramphenicol, has been given trial in 28 patients: acute gonococcal urethritis 10, nongonococcal urethritis 7, acute cystitis 6, chancroid 1 and postoperative cases 4. The doses ranged from 300 to 600 me daily. From this study, it was found that Protermycin proved itself to be most effective in nongonococcal urethritis which could not be treated satisfactorily by other antibiotics. Of 28 cases, 25 showed good result. The remaining 3 cases failed to respond.

Keyword

protermycin

MeSH Terms

Anti-Bacterial Agents
Chancroid
Chloramphenicol
Cystitis
Humans
Tetracycline
Urethritis
Anti-Bacterial Agents
Chloramphenicol
Tetracycline
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr